Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Patient
77%
Lower Urinary Tract Symptom
70%
Health
60%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
55%
COVID-19
55%
Symptom
49%
Therapeutic Procedure
48%
Age
45%
Placebo
43%
Bladder
40%
Glycon
38%
Protein
37%
Vaccine
34%
Analysis
33%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
Serotype
32%
Fluvoxamine
28%
Ivermectin
28%
Woman
28%
Pneumococcus Polysaccharide
27%
Polysaccharide Vaccine
27%
Development
27%
Amaurosis
27%
Immunogenicity
22%
Immunoglobulin G
22%
Antibody
20%
Outpatient
20%
Child
19%
Immune Response
18%
Conjugate
18%
Pneumococcus Vaccine
18%
Public Health
18%
Prospective Cohort Study
18%
Prospective Study
18%
Percutaneous Endoscopic Gastrostomy
18%
Alcohol Consumption
18%
Respiratory Disease
18%
Interference
18%
Sleep Quality
18%
Opsonization
18%
Chronic Pelvic Pain Syndrome
18%
Incidence
18%
Health Behavior
18%
Disease
18%
Kerosene
18%
Zileuton
18%
Glycan
18%
Drug Therapy
17%
Odds Ratio
16%
Nursing and Health Professions
Prevention
70%
Obstructive Lung Disease
37%
Analysis
24%
Confidence Interval
24%
Time
18%
Workplace
18%
Diseases
18%
Metformin
18%
Young Adult
18%
Girl
18%
Fluvoxamine
18%
Sleep Quality
18%
Toileting
18%
Parent
18%
Child
18%
Drug Therapy
13%
Female
13%
Placebo
11%
Control
11%
Lived Experience
9%
Job
9%
Content Analysis
9%
Adult
9%
Gender
9%
Woman
9%
World Health Organization
9%
Anti Reflux Implant
9%
Coding
9%
Contrast
9%
Odds Ratio
9%
Hospitalization
8%
Death
8%
Pittsburgh Sleep Quality Index
7%
Disease Exacerbation
6%
Emergency Ward
6%
Severe Acute Respiratory Syndrome
6%
Quality of Life
6%